Effect of non steroidal anti-inflammatory eye drop(nepafenac) on eye(choroidal thickness) of diabetic patients without retinopathy (an end organ damage affecting eye) following cataract surgery
Not Applicable
- Conditions
- Health Condition 1: H309- Unspecified chorioretinal inflammation
- Registration Number
- CTRI/2024/05/066781
- Lead Sponsor
- nil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diabetic patients with no clinical evidence of diabetic retinopathy who have senile immature cataract (gr 2, gr 3) scheduled to undergo cataract extraction and posterior chamber Intra-ocular lens implantation
Exclusion Criteria
1. Anterior segment pathology (corneal opacities, PEX, dense cataract)
2. Posterior segment pathology (DR, ARMD, retinal vascular diseases, uveitis)
3. Intra & Postoperative complications(TASS, raised IOP)
4.History of chronic oral/topical medication, intraocular surgery, ocular trauma.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Choroidal thickness measurements at 5 points (sub-foveal, 500µm temporal, nasal, superior & inferior to fovea) measured using EDI-OCTTimepoint: Choroidal thickness measurements at 5 points using EDI-OCT on preoperative day, post operative 1 week and post op 1 month
- Secondary Outcome Measures
Name Time Method Compare subfoveal choroidal thickness at 3 months post op with initial pre op readingTimepoint: 3 months